Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 4.9 | 0.3 | -3.5 | -1.0 | 2.9 | -3.4 |
| Revenue growth | 1730.3% | -107.7% | 240.7% | -135.1% | -184.2% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 4.9 | 0.3 | -3.5 | -1.0 | 2.9 | -3.4 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 36.4 | 36.8 | 25.9 | 19.7 | 16.8 | 17.7 |
| General and administrative | 7.3 | 8.5 | 7.1 | 6.0 | 5.2 | 4.6 |
| EBIT | -38.8 | -45.1 | -36.4 | -26.7 | -19.1 | -25.7 |
| EBIT margin | -794.6% | -16889.9% | 1049.0% | 2620.2% | -659.1% | 745.2% |
| Pre-tax income | -38.5 | -47.8 | -36.2 | -25.7 | -18.1 | -25.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|